Condition

Refractory Follicular Lymphoma clinical trials and research

• 6Clinical trials
• 2Countries

Newest Refractory Follicular Lymphoma clinical trials

All recruiting trials (6)

• Pirtobrutinib plus Mosunetuzumab for relapsed or refractory grade 1–3a follicular lymphoma

  This trial tests whether giving pirtobrutinib together with mosunetuzumab can better treat adults with relapsed or refractory grade 1–3a follicular lymphoma.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT06948786

• Q702 to treat blood cancers

  This Phase 1 trial will test whether the oral drug Q702 is safe, tolerable, and what dose works best for adults with certain blood cancers who have failed or are not eligible for standard treatments.

  Recruiting at 2 sites Phase 1 Mayo Clinic · Scottsdale, Arizona and 1 other locations · NCT06712810

• Treatment using modified T-cells for relapsed or refractory B-cell cancers

  This study is testing a new treatment that uses specially modified T-cells to see if it can help people with hard-to-treat B-cell cancers.

  Recruiting Phase 1 Mayo Clinic · Jacksonville, Florida · NCT06191887

• New treatment for relapsed follicular lymphoma

  This study is testing a new treatment combining epcoritamab and lenalidomide for people with relapsed follicular lymphoma to see if it works better than the usual treatments.

  Recruiting at 2 sites Phase 2 University of Birmingham · Aberdeen and 24 other locations · NCT05848765

• Combining brentuximab vedotin and bendamustine for treating relapsed or refractory follicular lymphoma

  This study is testing if combining two drugs, brentuximab vedotin and bendamustine, can help people with relapsed or hard-to-treat follicular lymphoma feel better and improve their chances of recovery.

  Recruiting Phase 2 University of California, Davis · Sacramento, California · NCT04587687

• Donor stem cell transplant with chemotherapy and radiation for blood cancers

  This study is testing if a donor stem cell transplant combined with different doses of chemotherapy and radiation can help people with blood cancers recover better.

  Recruiting Phase 2 Fred Hutchinson Cancer Center · Seattle, Washington · NCT04195633

Related topics

Quick answers

How many Refractory Follicular Lymphoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (5 trials), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →